BDBM71794 1-(4-bromanyl-3,5-dimethyl-pyrazol-1-yl)-3-(2,3,5-trimethylindol-1-yl)propan-2-ol::1-(4-bromo-3,5-dimethyl-1-pyrazolyl)-3-(2,3,5-trimethyl-1-indolyl)-2-propanol::1-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)-3-(2,3,5-trimethyl-1H-indol-1-yl)-2-propanol::1-(4-bromo-3,5-dimethyl-pyrazol-1-yl)-3-(2,3,5-trimethylindol-1-yl)propan-2-ol::1-(4-bromo-3,5-dimethylpyrazol-1-yl)-3-(2,3,5-trimethylindol-1-yl)propan-2-ol::MLS000097284::SMR000075830::cid_2951711
SMILES Cc1nn(CC(O)Cn2c(C)c(C)c3cc(C)ccc23)c(C)c1Br
InChI Key InChIKey=FHCSRVMNNAWHFG-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 71794
TargetIsoform PDE10A2 of cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (PDE10A2)(Human)
Daiichi Sankyo
US Patent
Daiichi Sankyo
US Patent
Affinity DataIC50: 0.290nMpH: 7.5 T: 2°CAssay Description:A human acute lymphoblastic lymphoma T cell line MOLT-4 (which can be purchased under ATCC No. CRL-1582 from ATCC) was cultured in an RPMI1640 medium...More data for this Ligand-Target Pair
